Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Reymer

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Human Molecular Genetics|September 1, 1995
A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemiaP W Reymer, B E Groenemeyer, E Gagné, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 1, 1995
Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291-->Ser mutation in the human LPL geneH Zhang, P W Reymer, M S Liu, et al.
Atherosclerosis|January 26, 1996
The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemiaM J Hoffer, S J Bredie, D I Boomsma, et al.
Atherosclerosis|July 25, 1998
Gender-related association between the -93T-->G/D9N haplotype of the lipoprotein lipase gene and elevated lipid levels in familial combined hyperlipidemiaM J Hoffer, S J Bredie, H Snieder, et al.
Journal of Lipid Research|April 7, 1999
Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteinsH E Henderson, J J Kastelein, A H Zwinderman, et al.
Circulation|June 17, 1997
Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study GroupB E Groenemeijer, M D Hallman, P W Reymer, et al.
Clinical Genetics|April 29, 1998
The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study GroupJ J Kastelein, B E Groenemeyer, D M Hallman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Ethnic variation and in vivo effects of the -93t-->g promoter variant in the lipoprotein lipase geneE Ehrenborg, S M Clee, S N Pimstone, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Human Molecular Genetics|September 1, 1995
A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemiaP W Reymer, B E Groenemeyer, E Gagné, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 1, 1995
Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291-->Ser mutation in the human LPL geneH Zhang, P W Reymer, M S Liu, et al.
Atherosclerosis|January 26, 1996
The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemiaM J Hoffer, S J Bredie, D I Boomsma, et al.
Atherosclerosis|July 25, 1998
Gender-related association between the -93T-->G/D9N haplotype of the lipoprotein lipase gene and elevated lipid levels in familial combined hyperlipidemiaM J Hoffer, S J Bredie, H Snieder, et al.
Journal of Lipid Research|April 7, 1999
Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteinsH E Henderson, J J Kastelein, A H Zwinderman, et al.
Circulation|June 17, 1997
Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study GroupB E Groenemeijer, M D Hallman, P W Reymer, et al.
Clinical Genetics|April 29, 1998
The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study GroupJ J Kastelein, B E Groenemeyer, D M Hallman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Ethnic variation and in vivo effects of the -93t-->g promoter variant in the lipoprotein lipase geneE Ehrenborg, S M Clee, S N Pimstone, et al.
Pageof 2